Moxifloxacin |
|
|---|---|
| CAT. No : | M060085 |
| CAS. No : | 151096-09-2 |
| Mol. F : | C21H24FN3O4 |
| Mol. Wt : | 401.43 g/mol |
| Synonyms : | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid |
| Chemical Name : | 3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo |
| Stock Status : | Custom Synthesis |
- Buy High-Quality Moxifloxacin Reference Standards, Impurity Standards, Metabolites, Analytical Standards, Pharmacopoeial & Non-Pharmacopoeial Standards from Simson Pharma.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Buy 151096-09-2 | Purchase 151096-09-2 | Order 151096-09-2 | Enquire 151096-09-2 | Price of 151096-09-2 | 151096-09-2 Supplier | 151096-09-2 Manufacturer | 151096-09-2 Exporter | Moxifloxacin for Method Validation | Moxifloxacin Reference Standard | Moxifloxacin for ANDA Filing | Moxifloxacin for Forced Degradation Studies | Moxifloxacin Identification Standards | Moxifloxacin for DMF Filing | Buy high quality Moxifloxacin | Purchase Moxifloxacin | Moxifloxacin suppliers | Moxifloxacin manufacturers | Moxifloxacin price | Moxifloxacin exporter | Order Moxifloxacin | Enquire Moxifloxacin | Moxifloxacin cost | Moxifloxacin Supplier | Moxifloxacin Distributor
Related Products
Discover all
![cis-Octahydropyrrolo[3,4-b]pyridine](https://www.simsonpharma.com/admin/uploads/products/m060028.jpg)
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
